biohack.The longevity wire
LIVE WIREUpdated · scanning every 6 hours
12:01 A daily pill for male hair loss passed its second big trial, maker says✦12:15 A popular longevity supplement didn’t slow Parkinson’s in a large trial✦12:04 Drugmakers say Ozempic-style drugs slowed lab measures of aging✦12:03 Gene therapy that aims to make eye cells act younger is tried in 3 people✦15:22 Alzheimer's drug tested in healthy people to see if it can prevent disease✦15:12 AI-designed lung drug made patients' blood look younger on 6 aging tests✦14:54 One-time brain gene therapy for Huntington's is sent for US, UK approval✦12:01 A daily pill for male hair loss passed its second big trial, maker says✦12:15 A popular longevity supplement didn’t slow Parkinson’s in a large trial✦12:04 Drugmakers say Ozempic-style drugs slowed lab measures of aging✦12:03 Gene therapy that aims to make eye cells act younger is tried in 3 people✦15:22 Alzheimer's drug tested in healthy people to see if it can prevent disease✦15:12 AI-designed lung drug made patients' blood look younger on 6 aging tests✦14:54 One-time brain gene therapy for Huntington's is sent for US, UK approval
← All topicsTOPIC

Longevity Business.

The companies, money and deals behind the longevity industry.

No stories on this beat yet.

We scan for new developments every 6 hours. The first one will appear here.